Ultimo aggiornamento: agosto 17, 2026
- Terapia genica per il potenziamento cognitivo del sistema nervoso centrale e terapia genica duale – Terapia genica con follistatina e telomerasi
2) Dementia Intranasal Gene Therapy
Klotho Links To Articles
The Putative Role of the Antiageing Protein Klotho in Cardiovascular and Renal Disease
https://www.hindawi.com/journals/ijhy/2012/757469/
Klotho at the Edge of Alzheimer’s Disease and Senile Depression
https://www.ncbi.nlm.nih.gov/pubmed/29978424
Is Klotho the Key to Treating Alzheimer’s and Other Diseases of Aging?
https://www.biospace.com/article/is-klotho-the-key-to-treating-alzheimer-s-and-other-diseases-of-aging-/
One Day There May Be a Drug to Turbocharge the Brain.
https://www.nytimes.com/2019/04/02/health/klotho-brain-enhancement-dementia-alzheimers.html
Follistatin Links to Articles
“Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy Patricio V. Sepulveda https://www.nature.com/articles/srep17535 WEB 2015
Abellan van Kan, G. “Epidemiology and consequences of sarcopenia.” The journal of nutrition, salute & invecchiamento 13.8 (2009): 708-712.
Amthor, Helge, et al. “Lack of myostatin results in excessive muscle growth but impaired force generation.” Atti dell'Accademia Nazionale delle Scienze 104.6 (2007): 1835-1840.
Amthor, Helge, and Willem MH Hoogaars. “Interference with myostatin/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy.” Current gene therapy 12.3 (2012): 245-259.
Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancetta 2003;361:1077–83.
Argiles JM, Anker SD, Evans WJ, et al. Consensus on cachexia definitions. J Am Med Dir Assoc 2010;11:229–30
Artaza JN, Singh R, Ferrini MG, Braga M, Tsao J, Gonzalez-Cadavid NF. Myostatin
promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting
their differentiation into myofibroblasts. J Endocrinol 2008;196:235–49
Barns, Mitchell, et al. “Molecular analyses provide insight into mechanisms underlying sarcopenia and myofibre denervation in old skeletal muscles of mice.” The international journal of biochemistry & biologia cellulare 53 (2014): 174-185.
Bartke, Andrzej. “Growth hormone and aging: a challenging controversy.” Clin Interv Aging 3.4 (2008): 659-665.
Becker, Clemens, et al. “Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial.” The lancet Diabetes & endocrinology 3.12 (2015): 948-957.
Benny Klimek ME, Aydogdu T, Link MJ, Pons M, Koniaris LG, Zimmers TA. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem Biophys Res Commun. 2010;391:1548–54.
Berardi, Emanuele, et al. “Molecular and cell-based therapies for muscle degenerations: a road under construction.” Frontiers in physiology 5 (2014): 119.
Revisione scientifica del caso
Ti piacerebbe capire se i programmi clinici sono attuali, recenti sviluppi della ricerca, o potrebbero esserlo gli approcci emergenti rilevante per la tua situazione individuale?
Invia la tua domanda al nostro team scientifico. La sede centrale di NBScience nel Regno Unito coordina le richieste attraverso la rete internazionale di centri medici, scienziati, e consulenti specializzati.
- Revisione delle informazioni fornite
- Informazioni rilevanti sulla ricerca e sul programma clinico
- Una risposta chiara focalizzata sulla tua situazione
Nessun obbligo. La tua domanda verrà esaminata in modo confidenziale.
Solo informazioni didattiche e di ricerca. Questo servizio no costituiscono un parere medico, diagnosi, prescrizione, o uno personalizzato raccomandazione terapeutica.
